Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › oxcarbazepine

oxcarbazepine

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of oxcarbazepine

9 trials tracked of oxcarbazepine: 2 in phase 3 or 4.

9Trials tracked
2Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 2 Phase 1 6 Other / NA 1
  1. Phase 4 Effect of Oxcarbazepine on Serum Brain Derived Neurotrophic Factor (BDNF) in Bipolar Disorder Completed
  2. Phase 4 Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial Epilepsy Completed
  3. Phase 1 Oxcarbazepine 600 mg Tablets Under Non-Fasting Conditions Completed
  4. Phase 1 A Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazepine on Padsevonil Completed
  5. Phase 1 Tolerability and Pharmacokinetics of a Single 900 mg Oral Dose of BIA 2-093 and Oxcarbazepine in Healthy Volunteers Completed
  6. Phase 1 Oxcarbazepine 600 mg Tablets Under Fasting Conditions Completed
Show 3 more trials
  1. Phase 1 Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy Volunteers Completed
  2. Phase 1 Study to Evaluate Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and Oxcarbazepine Completed
  3. N/A Oxcarbazepine Versus Placebo in Childhood Autism Completed

Showing the 9 most-cited and recently-updated of 9 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Systematic review and meta-analysis of mood stabilizers for nonsuicidal self-injury in adolescents
Psychiatry Meta-analysis
Systematic review and meta-analysis of mood stabilizers for nonsuicidal self-injury in adolescents Mood stabilizers show promise for teen self-injury and depression in China
This systematic review and meta-analysis examined nine studies from China involving adolescent patients with nonsuicidal self-injury. The au…
A review of nine studies suggests mood stabilizers may help reduce self-injury and depression in Chinese adolescents, offering new options f…
May 20, 2026
Low-dose carbamazepine or oxcarbazepine controlled dyskinetic attacks in six pediatric patients with paroxysmal kinesigenic dyskinesia
Neurology Cohort
Low-dose carbamazepine or oxcarbazepine controlled dyskinetic attacks in six pediatric patients with paroxysmal kinesigenic dyskinesia Sudden Movements Stop With One Pill
This retrospective cohort study evaluated six pediatric patients with paroxysmal kinesigenic dyskinesia (PKD) treated with low-dose carbamaz…
A single pill stops sudden jerking attacks in children with a rare movement disorder, ending years of ineffective treatment and parental wor…
Frontiers Apr 10, 2026